Clock Drawing Test does not Differentiate Alzheimer’s Disease from Parkinson’s Disease Dementia
Objective: Our focus was on comparing the performance of CDT and MMSE in Parkinson’s Disease Dementia (PDD) and Alzheimer’s Disease (AD) patients. Background: The mini…Clinical characteristics of pain in Parkinson’s disease dementia
Objective: The aim of this study was the assess the prevalence of pain in Parkinson’s disease dementia, its clinical characteristics, and correlations with motor part…When and how to stop subthalamic deep brain stimulation in late-stage Parkinson’s disease
Objective: We sought to investigate the percentage of “poor stimulation responders” among late-stage Parkinson's disease (LSPD) patients for elaborating an algorithm to decide whether and…High Content Screening of synucleinopathy in primary cortical neurons : dissecting out the interplay between the basic synuclein pools
Objective: To set up a robust (see ref 1 for definition) 96-well High Content Screening assay of synucleinopathy in primary cultures of cortical neurons. Background:…Healthcare Resource Utilization and Costs of Parkinson’s Disease Dementia With Psychosis in the US Medicare Population
Objective: To describe healthcare resource use (HCRU) and related costs among Parkinson’s patients with dementia (PDD) and psychosis compared with other dementia types in a…Comparative Grey and White Matter Tau Pathology in LBD and PSP using Digital Histologic Measurements
Objective: To compare the regional distribution of cortical tau pathology between Lewy body disorders (LBD: Parkinson’s disease and dementia with Lewy bodies (DLB)) and progressive…Synaptic function in Parkinson’s disease associated with GBA mutations
Objective: To investigate the pathological substrate of impaired cognition in Parkinson’s disease (PD) associated with glucocerebrosidase (GBA) mutation. Background: Mutations in glucocerebrosidase gene (GBA), originally…The effect of coexistent neurodegenerative disorders on the clinical features of idiopathic normal pressure hydrocephalus
Objective: To determine the prevalence of neurodegenerative disorders in idiopathic normal pressure hydrocephalus (iNPH) and their effects on the clinical features of iNPH. Background: To…Biomarkers of the Level of Cognitive Impairment (CI) in patients with Parkinson’s Disease (PD): MRS study
Objective: The concentrations of NAA, Cr, mIns, and Glx are identified as putative neurochemical markers of CI in patients with PD. Background: On the basis…Using Quantitative Susceptibility Mapping to Predict Dementia in Parkinson’s Disease
Objective: To investigate how brain iron deposition relates to visual function and dementia risk in Parkinson’s Disease (PD). Background: Oxidative stress due to brain iron…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »